We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,201 results
  1. Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies

    Purpose

    We hypothesized that severe tau burden in brain regions involved in direct or indirect pathways of the basal ganglia correlate with more...

    Christian Ferschmann, Konstantin Messerschmidt, ... Maximilian Scheifele in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 17 February 2024
  2. Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau

    Insoluble fibrillar tau, the primary constituent of neurofibrillary tangles, has traditionally been thought to be the biologically active, toxic form...

    Anastasie Mate De Gerando, Lindsay A. Welikovitch, ... Bradley T. Hyman in Acta Neuropathologica
    Article Open access 21 June 2023
  3. Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies

    The retina is a potential source of biomarkers for the detection of neurodegenerative diseases. Accumulation of phosphorylated tau (p-tau) in the...

    Frederique J. Hart de Ruyter, Tjado H. J. Morrema, ... Jeroen J. M. Hoozemans in Acta Neuropathologica
    Article 08 December 2022
  4. Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein

    Purpose

    There is an unmet need for compounds to detect fibrillar forms of alpha-synuclein (αSyn) and 4-repeat tau, which are critical in many...

    Jens Sobek, Junhao Li, ... Ruiqing Ni in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 02 July 2024
  5. Tau depletion in human neurons mitigates Aβ-driven toxicity

    Alzheimer’s disease (AD) is an age-related neurodegenerative condition and the most common type of dementia, characterised by pathological...

    Bryan Ng, Jane Vowles, ... Richard Wade-Martins in Molecular Psychiatry
    Article Open access 15 February 2024
  6. MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons

    Inclusions comprised of microtubule-associated protein tau (tau) are implicated in a group of neurodegenerative diseases, collectively known as...

    Hong Xu, Qi Qiu, ... Virginia M.-Y. Lee in Acta Neuropathologica
    Article Open access 12 March 2024
  7. Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies

    β-amyloid (Aβ) and tau aggregation as well as neuronal injury and atrophy (ATN) are the major hallmarks of Alzheimer’s disease (AD), and biomarkers...

    Anika Finze, Gloria Biechele, ... Matthias Brendel in Molecular Psychiatry
    Article Open access 26 July 2023
  8. Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration

    Frontotemporal lobar degeneration with MAPT pathogenic variants (FTLD-MAPT) has heterogeneous tau pathological inclusions postmortem, consisting of...

    Lucia A. A. Giannini, Daniel T. Ohm, ... David J. Irwin in Acta Neuropathologica
    Article Open access 06 September 2022
  9. Tau filaments with the chronic traumatic encephalopathy fold in a case of vacuolar tauopathy with VCP mutation D395G

    Dominantly inherited mutation D395G in the gene encoding valosin-containing protein causes vacuolar tauopathy, a type of behavioural-variant...

    Chao Qi, Ryota Kobayashi, ... Masato Hasegawa in Acta Neuropathologica
    Article 17 May 2024
  10. Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies

    Tauopathies are a heterogeneous group of neurologic diseases characterized by pathological axodendritic distribution, ectopic expression, and/or...

    Felix Langerscheidt, Tamara Wied, ... Hans Zempel in Journal of Neurology
    Article Open access 30 March 2024
  11. Friend or foe: role of pathological tau in neuronal death

    Neuronal death is one of the most common pathological hallmarks of diverse neurological diseases, which manifest varying degrees of cognitive or...

    Moxin Wu, Zhiying Chen, ... Ling-Qiang Zhu in Molecular Psychiatry
    Article 14 March 2023
  12. Tau reduction attenuates autism-like features in Fmr1 knockout mice

    Background

    Fragile X syndrome (FXS) is a leading cause of autism spectrum disorder (ASD) and resulted from a loss of the FMR1 -encoded fragile X...

    Shanshan Zhao, **angyu Jiang, ... Yun-wu Zhang in Molecular Autism
    Article Open access 07 November 2023
  13. Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice

    TMEM106B , a gene encoding a lysosome membrane protein, is tightly associated with brain aging, hypomyelinating leukodystrophy, and multiple...

    Tuancheng Feng, Huan Du, ... Fenghua Hu in Acta Neuropathologica
    Article 25 March 2024
  14. Identification of high-performing antibodies for the reliable detection of Tau proteoforms by Western blotting and immunohistochemistry

    Antibodies are essential research tools whose performance directly impacts research conclusions and reproducibility. Owing to its central role in...

    Michael J. Ellis, Christiana Lekka, ... M. Irina Stefana in Acta Neuropathologica
    Article Open access 18 May 2024
  15. Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus

    Widespread cortical accumulation of misfolded pathological tau proteins (ptau) in the form of paired helical filaments is a major hallmark of...

    Barbara Sárkány, Csaba Dávid, ... Tim J. Viney in Acta Neuropathologica
    Article Open access 11 June 2024
  16. Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells

    Purpose

    Tau/MAPT (microtubule associated protein tau) protein is actively studied for the pathologic consequences of its aberrant proteostasis in...

    Letizia Clementi, Samantha Sabetta, ... Adriano Angelucci in Journal of Cancer Research and Clinical Oncology
    Article Open access 31 March 2023
  17. Interplay of tau and functional network connectivity in progressive supranuclear palsy: a [18F]PI-2620 PET/MRI study

    Purpose

    Progressive supranuclear palsy (PSP) is primary 4-repeat tauopathy. Evidence spanning from imaging studies indicate aberrant connectivity in...

    Gayane Aghakhanyan, M. Rullmann, ... H. Barthel in European Journal of Nuclear Medicine and Molecular Imaging
    Article 01 September 2022
  18. Predictive Utility of Plasma Amyloid and Tau for Cognitive Decline in Cognitively Normal Adults

    Background

    Alzheimer’s disease (AD) is the most common neurodegenerative disease affecting mostly elderly adults. Recent diagnostic criteria for AD...

    Y.-J. Lee, S.-Y. Lin, ... I. H. Cheng in The Journal of Prevention of Alzheimer's Disease
    Article 25 January 2023
  19. p-tau Ser356 is associated with Alzheimer’s disease pathology and is lowered in brain slice cultures using the NUAK inhibitor WZ4003

    Tau hyperphosphorylation and aggregation is a common feature of many dementia-causing neurodegenerative diseases. Tau can be phosphorylated at up to...

    Lewis W. Taylor, Elizabeth M. Simzer, ... Claire S. Durrant in Acta Neuropathologica
    Article Open access 04 January 2024
  20. Tau PET imaging in progressive supranuclear palsy: a systematic review and meta-analysis

    Objectives

    To evaluate the difference of tau burden between patients with progressive supranuclear palsy (PSP) and healthy controls (HCs) or other...

    Jianing **, Dongning Su, ... Tao Feng in Journal of Neurology
    Article 12 January 2023
Did you find what you were looking for? Share feedback.